Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

NCT00036127 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.